Every 8-K that XBP Global Holdings, Inc. (XBP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow XBP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XBP filings page.
XBP Global Holdings reported second quarter 2026 results for the quarter ended June 30, 2026. Revenue was $191.3 million, compared with pro forma revenue of $222.5 million for the prior-year quarter, while pro forma gross margin was 21.5%. Adjusted Gross Margin reached 24.9%, the highest level to date.
The company reported a net loss of $16.7 million for the quarter, a substantial improvement from a net loss of $65.1 million in the prior-year period. Pro Forma Normalized EBITDA was $21.9 million, up from $20.2 million a year earlier. For the first half of 2026, net cash used in operating activities improved to $15.2 million from $75.9 million in the first half of 2025. Management highlighted a higher-margin revenue mix, benefits from its AI-first automation strategy, and raised its annualized efficiency target to $65–$75 million, with about $35 million expected in 2026. XBP Global also closed $121.3 million of total contract value in the quarter and has engaged a financial advisor in connection with previously announced strategic alternatives.
XBP Global Holdings, Inc. reported the results of its 2026 annual meeting of stockholders. As of the April 21, 2026 record date, there were 11,768,050 shares of common stock outstanding and entitled to vote, and approximately 85.92% of these shares were represented at the meeting.
Stockholders cast votes for each director nominee, with detailed "for," "withheld," and broker non-vote counts disclosed for seven nominees. Additional proposals also received specified votes for, against, and abstaining. Stockholders expressed a clear preference for holding future say-on-pay advisory votes every year.
Consistent with the Board’s prior recommendation, the company stated that future say-on-pay votes will occur on an annual basis until the next advisory vote on frequency, which will take place no later than the 2032 annual meeting of stockholders.
XBP Global Holdings, Inc. reported first quarter 2026 results showing modest revenue growth but a swing back to loss and much weaker profitability. For the quarter ended March 31, 2026, revenue was $197.1 million, while the company recorded a net loss of $26.8 million versus prior-year net profit.
On a pro forma basis, revenue declined to $197.1 million from $229.7 million, though gross margin improved slightly. Pro Forma Normalized EBITDA was $15.6 million, down from $26.0 million. The balance sheet showed total assets of $871.4 million, total liabilities of $808.9 million, and stockholders’ equity of $62.6 million.
The company highlighted ongoing cost discipline and automation, noting its third consecutive quarter of margin expansion and expectations for higher revenue per employee in the second half of the year. Separately, the board approved an exploration of strategic alternatives to evaluate options to enhance stakeholder value, with no assurance that this process will result in any transaction.
XBP Global Holdings, Inc. reported fourth quarter and full year 2025 results reflecting a major transition after acquiring Exela Technologies BPA. As reported full year 2025 revenue was $791.0 million, down from $872.7 million, while pro forma revenue was $879.6 million versus $1,017.6 million. As reported full year gross margin held near 21.7%, and pro forma gross margin was 21.9%. Fourth quarter 2025 revenue was $207.0 million, down 15.1% year over year, with gross margin improving to 22.7%. The company recorded a successor-period net loss of $351.1 million, driven largely by a $320.3 million goodwill impairment, while full year pro forma normalized EBITDA reached $90.2 million. Management highlighted sales investments and agentic AI-driven automation aimed at stabilizing the acquired business and supporting future growth.
XBP Global Holdings, Inc. disclosed that subsidiary XBP Americas, LLC entered into a Limited Waiver and Third Amendment to its asset-based Credit and Security Agreement on March 6, 2026. The amendment removes the covenant requiring minimum excess availability of $7.5 million.
The Third Amendment adds a temporary availability block through June 30, 2026, reducing borrowing capacity by the greater of $3.75 million or 5.0% of the borrowing base if the fixed charge coverage ratio falls below 1.00 to 1.00. It also temporarily raises the advance rate on eligible investment grade billed accounts to 95.0% through September 30, 2026 and adjusts borrowing base calculations, cash dominion mechanics, and the deferred revolving loan origination fee.
XBP Global Holdings, Inc. filed a new Certificate of Amendment to its Third Amended and Restated Certificate of Incorporation with the Delaware Secretary of State on December 12, 2025, and also filed two Certificates of Correction that void earlier charter amendments from July 29 and July 30, 2025.
The company explains that these corrective filings do not change the substance of its charter or its previously announced plans regarding its common stock, but instead replace the July 29 amendment and void a July 30 amendment that had purported to change the company’s name to a name change already in effect.
XBP Global Holdings, Inc. reported that it received a Nasdaq deficiency notice because the closing bid price of its common stock stayed below $1.00 for 30 consecutive business days from August 4 to September 15, 2025, violating Nasdaq’s minimum bid price rule. The company has a 180-day grace period, until March 16, 2026, to regain compliance by having its closing bid price at or above $1.00 for at least ten consecutive business days, a period Nasdaq may extend in certain cases. XBP notes that recent closing bid prices have been above $1.00 but cautions there is no assurance it will regain or maintain compliance. If it fails to do so, its stock could be delisted, though the company would have appeal rights. For now, the common stock and publicly traded warrants continue trading on the Nasdaq Capital Market under the symbols XBP and XBPW.